American Shared Hospital Services (NYSEAMERICAN:AMS) Sees Significant Drop in Short Interest

American Shared Hospital Services (NYSEAMERICAN:AMS) saw a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 5,436 shares, a decrease of 53.2% from the August 31st total of 11,622 shares. Based on an average daily volume of 10,354 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.1% of the shares of the company are short sold.

American Shared Hospital Services Stock Down 1.4%

Shares of NYSEAMERICAN:AMS traded down $0.02 during trading on Wednesday, hitting $1.42. 16,286 shares of the stock traded hands, compared to its average volume of 97,072. The company has a fifty day moving average price of $1.48 and a two-hundred day moving average price of $1.51. The company has a market cap of $9.44 million, a price-to-earnings ratio of -5.68 and a beta of 0.30. American Shared Hospital Services has a 52-week low of $1.25 and a 52-week high of $2.81.

American Shared Hospital Services (NYSEAMERICAN:AMS) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.05). American Shared Hospital Services had a negative net margin of 5.83% and a negative return on equity of 6.52%. The business had revenue of $8.43 million during the quarter, compared to analysts’ expectations of $7.56 million. On average, equities research analysts predict that American Shared Hospital Services will post -0.14 EPS for the current fiscal year.

About American Shared Hospital Services

American Shared Hospital Services (NYSEAMERICAN: AMS) is a healthcare services and medical technology company that provides hospitals and medical centers with access to advanced equipment and related services. Its business model is designed to help healthcare providers offer specialized treatments without bearing the full cost and operational responsibility of purchasing and managing complex medical technology.

The company has historically focused on radiation oncology and stereotactic radiosurgery, including Gamma Knife systems used in the treatment of brain disorders and tumors.